Clinical Trial Update: Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Tarceva, Temodar, and radiation therapy in newly diagnosed brain tumors (glioblastoma multiforme and gliosarcoma) completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Tarceva (erlotinib)
• Temodar (Temozolomide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Glioblastoma Multiforme, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2012-09-27